Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 1/2015

01-02-2015 | Review

Sepsis outside intensive care unit: the other side of the coin

Authors: F. Mearelli, D. Orso, N. Fiotti, N. Altamura, A. Breglia, M. De Nardo, I. Paoli, M. Zanetti, C. Casarsa, G. Biolo

Published in: Infection | Issue 1/2015

Login to get access

Abstract

Introduction

A growing body of evidence points out that a large amount of patients with sepsis are admitted and treated in medical ward (MW). With most of the sepsis studies conducted in intensive care unit (ICU), these patients, older and with more comorbidities have received poor attention. Provided the differences between the two groups of patients, results of diagnostic and therapeutic trials from ICU should not be routinely transferred to MW, where sepsis seems to be at least as common as in ICU.

Methods

We analyzed clinical trials on novel tools for an early diagnosis of sepsis published in the last two year adopting strict research criteria. Moreover we conducted a target review of the literature on non-invasive monitoring of severe sepsis and septic shock.

Results and Conclusions

The combination of innovative and non-invasive tools for sepsis rule in/out, as quick alternatives to blood cultures (gold standard) with bedside integrated ultrasonography could impact triage, diagnosis and prognosis of septic patients managed in MW, preventing ICU admissions, poor outcomes and costly complications, especially in elderly that are usually highly vulnerable to invasive procedures.
Appendix
Available only for authorised users
Literature
1.
Martin GS, Mannino DM, Eaton S, Moss M. The Epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–54.PubMedCrossRef
2.
Sepsis and multiorgan dysfunction. Abstracts of the 6th international congress, Weimer sepsis update 2013-consensus and controversies. September 4–6, 2013. Weimer, Germany. Infection. 2013;41(Suppl 1):1–90.
3.
Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(21):2063.PubMed
4.
Levy MM, Artigas A, Philips GS, Rhodes A, Beale R, Osborn T, Vincent JL, Townsend S, Lemeshow S, Dellinger RP. Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12:919–24.PubMedCrossRef
5.
Carmona-Torre F, Martinez-Urbistondo D, Landecho MF, Lucena JF. Surviving sepsis in an intermediate care unit. Lancet Infect Dis. 2013;13(4):294–5.PubMedCrossRef
6.
7.
Mearelli F, Fiotti N, Altamura N, Zanetti M, Fernandes G, Burekovic I, Occhipinti A, Orso D, Giansante C, Casarsa C, Biolo G (2013) Heterogeneous models for an early discrimination between sepsis and non-infective SIRS in medical ward patients: a pilot study. Intern Emerg Med Dec 22 [Epub ahead of print].
8.
Rohde JM, Odden AJ, Bonham C, Kuhn L, Malani PN, Chen LM, Flanders SA, Iwashyna TJ. The epidemiology of acute organ system dysfunction from severe sepsis outside of the intensive care unit. J Hosp Med. 2013;8(5):243–7.PubMedCentralPubMedCrossRef
9.
Stiermaier T, Herkner H, Tobudic S, Burgmann K, Staudinger T, Schellongowski P, Burgmann H. Incidence and long-term outcome of sepsis on general wards and in an ICU at the general hospital of Vienna: an observational cohort study. Wien Klin Wochenschr. 2013;125(11–12):302–8.PubMedCrossRef
10.
Esteban A, Frutos-Vivar F, Ferguson ND, Peñuelas O, Lorente JA, Gordo F, Honrubia T, Algora A, Bustos A, García G, Diaz-Regañón IR, de Luna RR. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med. 2007;35(5):1284–9.PubMedCrossRef
11.
Howell MD, Shapiro NI. Surviving sepsis outside the intensive care unit. Crit Care Med. 2007;35(5):1422–3.PubMedCrossRef
12.
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–77.PubMedCrossRef
13.
Powell ES, Sauser K, Cheema N, Pirotte MJ, Quattromani E, Avula U, Khare RK, Courtney DM. Severe sepsis in do-not-resuscitate patients: intervention and mortality rates. J Emerg Med. 2013;44(4):742–9.PubMedCrossRef
14.
Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167–74.PubMedCrossRef
15.
Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13(3):260–8.PubMedCentralPubMedCrossRef
16.
Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence 2013;4(8):17.
17.
18.
Heffner AC, Horton JM, Marchick MR, Jones AE. Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin Infect Dis. 2010;50(6):814–20.PubMedCentralPubMedCrossRef
19.
Phua J, Ngerng WJ, See KC, Tay CK, Kiong T, Lim HF, Chew MY, Yip HS, Tan A, Khalizah HJ, Capistrano R, Lee KH, Mukhopadhyay A. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care. 2013;17(5):R202.PubMedCentralPubMedCrossRef
20.
Pavon A, Binquet C, Kara F, Martinet O, Ganster F, Navellou JC, Castelain V, Barraud D, Cousson J, Louis G, Perez P, Kuteifan K, Noirot A, Badie J, Mezher C, Lessire H, Quantin C, Abrahamowicz M, Quenot JP, EPI demiology of Septic Shock (EPISS) Study Group. Profile of the risk of death after septic shock in the present era: an epidemiologic study. Crit Care Med. 2013;41(11):2600–9.PubMedCrossRef
21.
Otto GP, Kropf M, Sossdorf M, Recknagel P, Lösche W, Rödel J, Claus RA, Busch M. Screening for bacteremia in sepsis and renal failure using hemofilters for renal replacement therapy. Infection. 2013;41(2):387–90.PubMedCrossRef
22.
Groenewoudt M, Roest AA, Leijten FM, Stassen PM. Septic patients arriving with emergency medical services: a seriously ill population. Eur J Emerg Med 2013 Nov 6. [Epub ahead of print].
23.
Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–96.PubMedCrossRef
24.
Filbin MR, Arias SA, Camargo CA Jr, Barche A, Pallin DJ. Sepsis visits and antibiotic utilization in U.S. Emergency departments. Crit Care Med 2013 Nov 6. [Epub ahead of print].
25.
Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C, So AD, Bigdeli M, Tomson G, Woodhouse W, Ombaka E, Peralta AQ, Qamar FN, Mir F, Kariuki S, Bhutta ZA, Coates A, Bergstrom R, Wright GD, Brown ED, Cars O. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–98.PubMedCrossRef
26.
Bouza E. Consequences of Clostridium difficile infection: understanding the healthcare burden. Clin Microbiol Infect. 2012;18(Suppl 6):5–12.PubMedCrossRef
27.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest. 2009;136(5 Suppl):e28.PubMed
28.
Shapiro N, Howell MD, Bates DW, Angus DC, Ngo L, Talmor D. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med. 2006;48(5):583–90.PubMedCrossRef
29.
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250–6.PubMedCrossRef
30.
Zhao H, Heard SO, Mullen MT, Crawford S, Goldberg RJ, Frendl G, Lilly CM. An evaluation of the diagnostic accuracy of the 1991 American College of Chest Physicians/Society of Critical Care Medicine and the 2001 Society of Critical Care Medicine/European Society of Intensive Care Medicine/American College of Chest Physicians/American Thoracic Society/Surgical Infection Society sepsis definition. Crit Care Med. 2012;40(6):1700–6.PubMedCrossRef
31.
Vincent JL, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions: time for change. Lancet. 2013;381(9868):774–5.PubMedCrossRef
32.
Howell MD, Talmor D, Schuetz P, Hunziker S, Jones AE, Shapiro NI. Proof of principle: the predisposition, infection, response, organ failure sepsis staging system. Crit Care Med. 2011;39(2):322–7.PubMedCrossRef
33.
Granja C, Póvoa P, Lobo C, Teixeira-Pinto A, Carneiro A, Costa-Pereira A. The predisposition, infection, response and organ failure (Piro) sepsis classification system: results of hospital mortality using a novel concept and methodological approach. PLoS One 2013;8(1).
34.
Gray A, Ward K, Lees F, Dewar C, Dickie S, McGuffie C. STAG steering committee. The epidemiology of adults with severe sepsis and septic shock in Scottish emergency departments. Emerg Med J. 2013;30(5):397–401.PubMedCrossRef
35.
Kenzaka T, Okayama M, Kuroki S, Fukui M, Yahata S, Hayashi H, Kitao A, Sugiyama D, Kajii E, Hashimoto M. Importance of vital signs to the early diagnosis and severity of sepsis: association between vital signs and sequential organ failure assessment score in patients with sepsis. Intern Med. 2012;51(8):871–6.PubMedCrossRef
36.
Pierrakos and Vincent. Sepsis biomarkers: a review. Crit Care. 2010;14:1–18.
37.
38.
Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426–35.PubMedCrossRef
39.
Lipinska-Gediga M, Mierzchala M, Durek G. Pro-atrial natriuretic peptide (pro-ANP) level in patients with severe sepsis and septic shock: prognostic and diagnostic significance. Infection. 2012;40(3):303–9.PubMedCentralPubMedCrossRef
40.
Gros A, Roussel M, Sauvadet E, Gacouin A, Marque S, Chimot L, et al. The sensitivity of neutrophil CD64 expression as a biomarker of bacterial infection is low in critically ill patients. Intensive Care Med. 2012;38(3):445–52.PubMedCrossRef
41.
Uusitalo-Seppala R, Peuravuori H, Koskinen P, Vahlberg T, Rintala EM. Role of plasma bactericidal/permeability-increasing protein, group IIA phospholipase A2, C-reactive protein, and white blood cell count in the early detection of severe sepsis in the emergency department. Scand J Infect Dis. 2012;44(9):697–704.PubMedCrossRef
42.
Tromp M, Lansdorp B, Bleeker-Rovers CP, Gunnewiek JM, Kullberg BJ, Pickkers P. Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. J Infect. 2012;65(4):292–301.PubMedCrossRef
43.
Su L, Han B, Liu C, Liang L, Jiang Z, Deng J, et al. Value of soluble Trem-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis. 2012;18(12):157.CrossRef
44.
Wu Y, Wang F, Fan X, Bao R, Bo L, Li J, Deng X. Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis. Crit Care 2012;16(6):R229.
45.
Feng L, Zhou X, Su LX, Feng D, Jia YH, Xie LX. Clinical significance of soluble hemoglobin scavenger receptor CD163 (sCD163) in Sepsis, a prospective study. PLoS One. 2012;7(7):e38400.PubMedCentralPubMedCrossRef
46.
Hoenigl M, Raggam RB, Wagner J, Valentin T, Leitner E, Seeber K, et al. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome. Clin Biochem. 2013;46(3):225–9.PubMedCrossRef
47.
Endo S, Suzuki Y, Takahashi G, Shozushiuma T, Ishikura H, Murai A, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012;18(6):891–7.PubMedCrossRef
48.
Tsalik EL, Jaggers LB, Glickman SW, Langley RJ, van Velkinburgh JC, Park LP, et al. Dicrimative value of inflammatory biomarkers for suspected sepsis. J Emerg Med. 2012;43(1):97–106.PubMedCentralPubMedCrossRef
49.
Gibot S, Béné MC, Noel R, Massin F, Guy J, Cravoisy A, et al. Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med. 2012;186(1):65–71.PubMedCrossRef
50.
Gille-Johnson P, Hansson KE, Gardlund B. Clinical and laboratory variables identifying bacterial infection and bacteremia in the emergency department. Scand J Infect Dis. 2012;44(10):745–52.PubMedCrossRef
51.
Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie LX. Evidence for serum miR-15a, and miR-16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects. Clin Chem Lab Med. 2012;50(8):1423–8.PubMedCrossRef
52.
Jaimes FA, De La Rosa GD, Valencia ML, Arango CM, Gomez CI, Garcia A, et al. A latent class approach for sepsis diagnosis supports use of procalcitonin in the emergency room for diagnosis of severe sepsis. BMC Anesthesiol. 2013;13(1):23.PubMedCentralPubMedCrossRef
53.
Al Shuaibi M, Bahu RR, Chaftari AM, Al Wohoush I, Shomali W, Jiang Y, et al. Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clin Infect Disease. 2013;58(7):943–50.CrossRef
54.
Jekarl DW, Lee SY, Lee J, Park YJ, Kim Y, Wee JH, et al. Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis. 2013;75(4):342–7.PubMedCrossRef
55.
Ulla M, Pizzolato E, Lucchiari M, Loiacono M, Soardo F, Forno D, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care. 2013;17(4):R168.PubMedCentralPubMedCrossRef
56.
Llewelyn MJ, Berger M, Gregory M, Ramaiah R, Taylor AR, Curdt L, et al. Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care. Crit Care. 2013;17(2):R60.PubMedCentralPubMedCrossRef
57.
Su L, Feng L, Song Q, Kang H, Zhang X, Liang Z, et al. Diagnostic value of dynamics serum sCD163, sTREM-1, PCT, and CRP in differentiating sepsis, severity assesment, and prognostic prediction. Mediators Inflamm. 2013;2013:969875.PubMedCentralPubMed
58.
59.
Ratzinger F, Schuardt M, Eichbichler K, Tsirkinidou I, Bauer M, Haslacher H, et al. Utility of sepsis biomarkers and the infection probability score to discriminate sepsis and systemic inflammatory response syndrome in standard care patients. PLoS One. 2013;8(12):e82946.PubMedCentralPubMedCrossRef
60.
Liu B, Chen YX, Yin Q, Zhao YZ, Li CS. Diagnostic value and prognostic evaluation of presepsin for sepsis in an emergency department. Crit Care. 2013;17(5):R244.PubMedCentralPubMedCrossRef
61.
Dimoula A, Pradier O, Kassengera Z, Dalcomune D, Turkan H, Vincent JL. Serial determinations of neutrophil CD64 expression for the diagnosis and monitoring of sepsis in critically ill patients. Clin Infect Dis 2014 Jan 28.
62.
Pons-Salort M, Thiébaut AC, Guillemot D, Favre M, Delarocque-Astagneau E. HPV genotype replacement: too early to tell. Lancet Infect Dis. 2013;13(12):1012.PubMedCrossRef
63.
Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2010;38(11):2229–41.PubMedCrossRef
64.
Bafadhel M, Clark TW, Reid C, Medina MJ, Batham S, Barer MR, Nicholson KG, Brightling CE. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Chest. 2011;139(6):1410–8.PubMedCentralPubMedCrossRef
65.
Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Evid Based Child Health. 2013;8(4):1297–371.PubMedCrossRef
66.
Heyland DK, Johnson AP, Reynolds SC, Muscedere J. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Crit Care Med. 2011;39(7):1792–9.PubMedCrossRef
67.
Jensen JU, Hein L, Lundgren B, Bestle MH, Mohr TT, Andersen MH, Thornberg KJ, Løken J, Steensen M, Fox Z, Tousi H, Søe-Jensen P, Lauritsen AØ, Strange D, Petersen PL, Reiter N, Hestad S, Thormar K, Fjeldborg P, Larsen KM, Drenck NE, Ostergaard C, Kjær J, Grarup J, Lundgren JD. Procalcitonin And Survival Study (PASS) Group.: procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med. 2011;39(9):2048–58.PubMedCrossRef
68.
Layios N, Lambermont B, Canivet JL, Morimont P, Preiser JC, Garweg C, Ledoux D, Frippiat F, Piret S, Giot JB, Wiesen P, Meuris C, Massion P, Leonard P, Nys M, Lancellotti P, Chapelle JP, Damas P. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med. 2012;40(8):2304–9.PubMedCrossRef
69.
Rivers EP, Jaehne AK, Nguyen HB, Papamatheakis DG, Singer D, Yang JJ, Brown S, Klausner H. Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: not a time to give up, but to give it earlier. Shock. 2013;39(2):127–37.PubMed
70.
Xiong C, McKeel DW Jr, Miller JP, Morris JC. Combining correlated diagnostic tests: application to neuropathologic diagnosis of Alzheimer’s disease. Med Decis Making. 2004;24(6):659–69.PubMedCrossRef
71.
Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, Larsen K. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care. 2007;11(2):R38.PubMedCentralPubMedCrossRef
72.
Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Köhl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med. 2000;28(8):2793–8.PubMedCrossRef
73.
74.
Kotsaki A, Giamarellos-Bourboulis EJ. Molecular diagnosis of sepsis. Expert Opin Med Diagn. 2012;6(3):209–19.PubMedCrossRef
75.
Lyle N, Boyd J. The potential for PCR based testing to improve diagnosis and treatment of sepsis. Curr Infect Dis Rep. 2013;15(5):372–9.PubMedCrossRef
76.
Riedel S, Carroll KC. Laboratory detection of sepsis: biomarkers and molecular approaches. Clin Lab Med. 2013;33(3):413–37.PubMedCrossRef
77.
Chang SS, Hsieh WH, Liu TS, Lee SH, Wang CH, Chou HC, Yeo YH, Tseng CP, Lee CC. Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis—a systemic review and meta-analysis. PLoS One. 2013;8(5):e62323.PubMedCentralPubMedCrossRef
78.
Jones AE, Brown MD, Trzeciak S, Shapiro NI, Garrett JS, Heffner AC, Kline JA. Emergency Medicine Shock Research Network investigators. The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis. Crit Care Med. 2008;36(10):2734–9.PubMedCentralPubMedCrossRef
79.
Jones AE, Kline JA. Use of goal-directed therapy for severe sepsis and septic shock in academic emergency departments. Crit Care Med 2005;33(8):1888–1889; author reply 1889–90.
80.
Biston P, Aldecoa C, Devriendt J, Madl C, Chochrad D, Vincent JL, De Backer D. Outcome of elderly patients with circulatory failure. Intensive Care Med;40(1):50–56.
81.
Ihra GC, Lehberger J, Hochrieser H, Bauer P, Schmutz R, Metnitz B, Metnitz PG. Development of demographics and outcome of very old critically ill patients admitted to intensive care units. Intensive Care Med. 2012;38(4):620–6.PubMedCrossRef
82.
Bourcier JE, Paquet J, Seinger M, Gallard E, Redonnet JP, Cheddadi F, Garnier D, Bourgeois JM, Geeraerts T. Performance comparison of lung ultrasound and chest X-ray for the diagnosis of pneumonia in the ED. Am J Emerg Med. 2014;32(2):115–8.PubMedCrossRef
83.
Cibinel GA, Casoli G, Elia F, Padoan M, Lupia E, Goffi A. Diagnostic accuracy and reproducibility of pleural and lung ultrasound in discriminating cardiogenic causes of acute dyspnea in the emergency department. Intern Emerg Med. 2012;7(1):65–70.PubMedCrossRef
84.
Jones AE, Tayal VS, Sullivan DM, Kline JA. Randomized, controlled trial of immediate versus delayed goal-directed ultrasound to identify the cause of nontraumatic hypotension in emergency department patients. Crit Care Med. 2004;32(8):1703–8.PubMedCrossRef
85.
Volpicelli G, Lamorte A, Tullio M, Cardinale L, Giraudo M, Stefanone V, Boero E, Nazerian P, Pozzi R, Frascisco MF. Point-of-care multiorgan ultrasonography for the evaluation of undifferentiated hypotension in the emergency department. Intensive Care Med. 2013;39(7):1290–8.PubMedCrossRef
86.
Bouferrache K, Amiel JB, Chimot L, Caille V, Charron C, Vignon P, Vieillard-Baron A. Initial resuscitation guided by the Surviving Sepsis Campaign recommendations and early echocardiographic assessment of hemodynamics in intensive care unit septic patients: a pilot study. Crit Care Med. 2012;40(10):2821–7.PubMedCrossRef
87.
Haydar SA, Moore ET, Higgins GL 3rd, Irish CB, Owens WB, Strout TD. Effect of bedside ultrasonography on the certainty of physician clinical decision making for septic patients in the emergency department. Ann Emerg Med. 2012;60(3):346–58.PubMedCrossRef
88.
Nagdev AD, Merchant RC, Tirado-Gonzalez A, Sisson CA, Murphy MC. Emergency department bedside ultrasonographic measurement of the caval index for noninvasive determination of low central venous pressure. Ann Emerg Med. 2010;55(3):290–5.PubMedCrossRef
89.
Schmidt GA, Koenig S, Mayo PH. Shock: ultrasound to guide diagnosis and therapy. Chest. 2012;142(4):1042–8.PubMedCrossRef
90.
Muller Laurent, Xavier Bobbia, Toumi Mehdi, Louart Guillame, Molinari Nicolas, Ragonnet Benoit, Quintard Herve, Leone Marc, Zoreic Lana, Lefrant Jean Yves and the AzuRea group. Respiratory variations of inferior cava diameter to predict fluid responsiveness in spontaneously breathing patients with acute circulatory failure: need for a cautions use. Critical Care 2012;(16):R188.
91.
Feissel M, Michard F, Faller JP, Teboul JL. The respiratory variation in inferior vena cava diameter as a guide to fluid therapy. Intensive Care Med. 2004;30(9):1834–7.PubMedCrossRef
92.
Zhang Z, Xu X, Ye S, Xu L. Ultrasonographic measurement of respiratory variation in the inferior vena cava diameter is predictive of fluid responsiveness in critically ill patients: systematic review and meta-analysis. Ultrasound in Med Biol 2014:1–9.
93.
Coen D, Vaccaro A, Cazzaniga M, Cortellaro F, Monti G, Tombini V. Toward a noninvasive approach to early goal-directed therapy. Chest 2011;139(3):726–727; author reply 727.
94.
Copetti R, Copetti P, Reissig A. Clinical integrated ultrasound of the thorax including causes of shock in nontraumatic critically ill patients. A practical approach. Ultrasound Med Biol. 2012;38(3):349–59.CrossRef
95.
Weekes AJ, Tassone HM, Babcock A, Quirke DP, Norton HJ, Jayarama K, Tayal VS. Comparison of serial qualitative and quantitative assessments of caval index and left ventricular systolic function during early fluid resuscitation of hypotensive emergency department patients. Acad Emerg Med. 2011;18(9):912–21.PubMedCrossRef
96.
Machare-Delgado E, Decaro M, Marik PE. Inferior vena cava variation compared to pulse contour analysis as predictors of fluid responsiveness: a prospective cohort study. J Intensive Care Med. 2011;26(2):116–24.PubMedCrossRef
97.
Howell MD, Donnino M, Clardy P, Talmor D, Shapiro NI. Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med. 2007;33(11):1892–9.PubMedCrossRef
98.
Jones AE. Point: should lactate clearance be substituted for central venous oxygen saturation as goals of early severe sepsis and septic shock therapy? Yes. Chest. 2011;140(6):1406–8.CrossRef
99.
Rivers EP, Elkin R, Cannon CM. Counterpoint: should lactate clearance be substituted for central venous oxygen saturation as goals of early severe sepsis and septic shock therapy? No. Chest 2011;140(6):1408–141. (Discussion 1413–1419).
100.
Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA. Emergency medicine shock research network (EMShockNet) investigators. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303(8):739–46.PubMedCentralPubMedCrossRef
101.
Puskarich MA, Trzeciak S, Shapiro NI, Albers AB, Heffner AC, Kline JA, Jones AE. Whole blood lactate kinetics in patients undergoing quantitative resuscitation for severe sepsis and septic shock. Chest. 2013;143(6):1548–53.PubMedCentralPubMedCrossRef
102.
Arnold RC, Shapiro NI, Jones AE, Schorr C, Pope J, Casner E, Parrillo JE, Dellinger RP, Trzeciak S. Emergency Medicine Shock Research Network (EMShockNet) Investigators. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock. 2009;32(1):35–9.PubMedCrossRef
103.
Miller RR, Dong L, Nelson NC, Brown SM, Kuttler KG, Probst DR, Allen TL, Clemmer TP. Intermountain Healthcare Intensive Medicine Clinical Program. Multicenter implementation of a severe sepsis and septic shock treatment bundle. Am J Respir Crit Care Med. 2013;188(1):77–82.PubMedCentralPubMedCrossRef
104.
The ProCESS Investigators. A randomized Trial of Protocol-Based Care for Early Septic Shock. N Engl J Med. 2014;18:1–11.
Metadata
Title
Sepsis outside intensive care unit: the other side of the coin
Authors
F. Mearelli
D. Orso
N. Fiotti
N. Altamura
A. Breglia
M. De Nardo
I. Paoli
M. Zanetti
C. Casarsa
G. Biolo
Publication date
01-02-2015
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 1/2015
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0673-6

Other articles of this Issue 1/2015

Infection 1/2015 Go to the issue

Case Report

Severe Staphylococcus lugdunensis keratitis

Brief Report

Severe thrombocytopenia in hantavirus-induced nephropathia epidemica

Original Paper

The revised dengue fever classification in German travelers: clinical manifestations and indicators for severe disease

Case Report

Beyond antibiotic selection: concordance with the IDSA guidelines for uncomplicated urinary tract infections

Images in Infection

Atypical presentation of herpetic whitlow as dark brown vesicles in a hyperbilirubinemic patient

Original Paper

Influence of intimal Chlamydophila pneumoniae persistence on cardiovascular complications after coronary intervention
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits